Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03993314 · ClinicalTrials.gov registry record · Phase 2
Optimizing Anesthesia for Post Partum Tubal Ligations
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT03993314 is a Phase 2 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 15 participants.
The verdict
NCT03993314, a Phase 2 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
In this study, the investigators will compare CLOROTEKAL® (1% spinal chloroprocaine) to low-dose isobaric bupivacaine using the epidural volume extension (EVE) technique in patients undergoing post-partum tubal ligation (PPBTL). This will be a randomized, double-blinded study. Patients scheduled for PPBTL at the Women and Infants Center (WIC) will be eligible for enrollment in this study. Outcomes measured will include: ability to achieve an adequate level required for surgery (T6), rate of epidural activation, and duration of the block. The investigators hope to determine the usefulness of each drug using the EVE technique in the setting of PPBTL.
Interventions
- DRUG Bupivacaine
- DRUG Chloroprocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-08-13 |
| Est. Completion | 2020-12-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03993314
The ClinicalTrials.gov registry entry for NCT03993314 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03993314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03993314 about?
NCT03993314 is a clinical study titled "Optimizing Anesthesia for Post Partum Tubal Ligations". In this study, the investigators will compare CLOROTEKAL® (1% spinal chloroprocaine) to low-dose isobaric bupivacaine using the epidural volume extension (EVE) technique in patients undergoing post-partum tubal ligation (PPBTL). This will be a randomized, double-blinded study. Patients scheduled for...
What is the current status of trial NCT03993314?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2019-08-13. Estimated completion is 2020-12-03.
What interventions are being tested in trial NCT03993314?
The interventions under investigation include: Bupivacaine (DRUG), Chloroprocaine (DRUG).
Who is sponsoring clinical trial NCT03993314?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.